In Brief: Glaxo Wellcome's Tritec
Executive Summary
Glaxo Wellcome's Tritec: Ranitidine bismuth citrate 400 mg tablets "approvable" at FDA March 29. Tritec with Abbott's Biaxin (clarithromycin) for eradication of Helicobacter pylori was recommended for approval by FDA's Gastrointestinal & Anti-Infective Drugs Advisory Committees on Dec. 11 ("The Pink Sheet" Dec. 18, 1995, p. 3)...